Disseminated Mucormycosis in Immunocompromised Children: Are New Antifungal Agents Making a Difference? A Multicenter Retrospective Study.

Sarah ElitzurSalvador FischerNira Arad-CohenAssaf BargMiriam Ben-HaroshDana DaninoRonit ElhasidAharon GefenGil GiladItzhak LevyYael Shachor-MeyouhasSigal WeinrebShai IzraeliShlomit Barzilai Birenboim

Published in: Journal of fungi (Basel, Switzerland) (2021)

Disseminated mucormycosis is a life-threatening and often fatal disease, and improved diagnostic and therapeutic strategies are needed. Nevertheless, in this population-based study, five patients (42%) were salvaged through combined liposomal amphotericin/triazole treatment and extensive surgical interventions.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
young adults
physical activity
peritoneal dialysis
candida albicans
patient reported outcomes
double blind
replacement therapy
respiratory failure
patient reported